ARAY
Accuray·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 1
Consensus Rating "Strong Buy"
Ample Liquidity
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ARAY
Accuray Incorporated
A company that develops radiosurgery and radiation therapy systems that deliver precise high dose radiation
Healthcare Equipment and Supplies
--
02/08/2007
NASDAQ Stock Exchange
990
06-30
Common stock
1240 Deming Way, Madison, Wisconsin 53717
--
Accuray Incorporated was incorporated in California in 1990 and began operations in 1992. The company was re-incorporated in Delaware in 2007. The company is a radiation oncology company that develops, manufactures, sells and supports precise, innovative therapeutic solutions and sets standards of care designed to help patients live longer and better lives. Its leading technology and tomotherapy systems, including the Radixact system, a next-generation tomotherapy platform, provide advanced radiotherapy, including radiosurgery, stereotactic body radiotherapy, intensity-modulated radiotherapy, image-guided radiotherapy and adaptive radiotherapy.
Earnings Call
Q3/2025
Estimate EPS-0.05
Actual EPS-0.01
Estimate Revenue101.53M
Actual Revenue113.24M
Navigating Contradictions: Insights from the 2025 Q3 Earnings Call on China Tariffs, Market Growth, and U.S. Recovery
May 07,2025 02:38
Earnings Decrypt
Earnings Decrypt
Q4/2025
Estimate EPS0.01
Actual EPS0.01
Estimate Revenue124.47M
Actual Revenue127.50M
Contradictions in Accuray's Q4 2025 Call: Navigating Tariffs, Market Demand, and Recovery Prospects
Aug 13,2025 07:22
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
ARAY has released its 2026 Q1 earnings. EPS was reported at -0.16, versus the expected -0.05, missing expectations. The chart below visualizes how ARAY has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ARAY has released its 2026 Q1 earnings report, with revenue of 93.94M, reflecting a YoY change of -7.49%, and net profit of -21.68M, showing a YoY change of -448.25%. The Sankey diagram below clearly presents ARAY's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
